Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
11Jan2026
  • Home
  • About
  • News
  • Subscribe
11Jan2026
Cost Curve NewsCost Curve News
Cost Curve News

Turmoil at the CDC Means that Vaccine Access Is Already Being Impacted in a Real Way

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
4 months ago
Keep Reading
Cost Curve News

Novo’s Latest Pharm-to-Table Deals Show How the Trend Is Evolving into an Ecosystem

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

People Are Getting Real Nervous About Premium Increases

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

The UK Is Suddenly a Flashpoint in the Battle Over Price and Access

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

Examining the Latest Launch Price: Ionis’ Dawnzera

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

European Tariffs — As Expected — Come in at 15%, But the Trade Deal Protects Against Even Bigger Levies

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

Health Spending Is Only Headed in One Direction — Up — and Employers Are Blaming the Meds

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

The Three (Generally Ignored) Forces Driving the Pharm-to-Table Trend

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

Hardly Anyone Is Using the Medicare Prescription Payment Plan

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

Lilly Takes a First Step in ‘Rebalancing’ U.S. and International Prices

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
8910

Latest Posts

J&J Becomes Company No. 15 to Make a Deal with the White House, Though Details Remain Sparse

January 9, 2026

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

January 8, 2026

Empty Offices, Full Coffers: A Journalistic Expose Examines How PBMs Use Group Purchasing Organizations to Profit

January 7, 2026

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

January 6, 2026

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

January 5, 2026

Popular

J&J Becomes Company No. 15 to Make a Deal with the White House, Though Details Remain Sparse

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

Empty Offices, Full Coffers: A Journalistic Expose Examines How PBMs Use Group Purchasing Organizations to Profit

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

Happy Festivus! Cost Curve Readers Have Some Grievances They’d Like to Air.

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (3,070)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (2,254)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (2,010)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,823)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,814)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

J&J Becomes Company No. 15 to Make a Deal with the White House, Though Details Remain Sparse

January 9, 2026

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

January 8, 2026

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2026 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe